carbamates has been researched along with daunorubicin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ghadially, FN; Skinnider, LF | 1 |
Choe, YH; Conover, CD; Greenwald, RB; Guan, S; Martinez, A; Pendri, A; Shum, K; Zhao, H | 1 |
Jordan, AM; Khan, TH; Malkin, H; Osborn, HM; Photiou, A; Riley, PA | 1 |
Bekaert, S; Cools, J; De Keersmaecker, K; Folens, C; Lahortiga, I; Marynen, P; Mentens, N; Odero, MD; Van Neste, L; Vandenberghe, P | 1 |
4 other study(ies) available for carbamates and daunorubicin
Article | Year |
---|---|
Giant mitochondria in erythroleukaemia.
Topics: Aged; Ampicillin; Bone Marrow; Bone Marrow Cells; Carbamates; Cephaloridine; Cyclophosphamide; Cytarabine; Daunorubicin; Environmental Exposure; Humans; Imines; Insecticides; Leukemia, Erythroblastic, Acute; Lysosomes; Macrophages; Male; Microscopy, Electron; Mitochondria; Pneumonia; Prednisone; Sulfides; Tetracycline; Thioguanine; Vincristine | 1974 |
Drug delivery systems employing 1,4- or 1,6-elimination: poly(ethylene glycol) prodrugs of amine-containing compounds.
Topics: Amines; Animals; Antineoplastic Agents; Carbamates; Carbonates; Cell Division; Daunorubicin; Drug Delivery Systems; Esters; Hydrolysis; Mice; Mice, Inbred Strains; Polyethylene Glycols; Prodrugs; Rats; Rats, Inbred Strains; Solubility; Tumor Cells, Cultured | 1999 |
Melanocyte-Directed enzyme prodrug therapy (MDEPT): development of second generation prodrugs for targeted treatment of malignant melanoma.
Topics: Agaricales; Carbamates; Daunorubicin; Drug Design; Drug Evaluation, Preclinical; Humans; Melanocytes; Melanoma; Monophenol Monooxygenase; Mustard Compounds; Nitrogen Mustard Compounds; Oxidation-Reduction; Prodrugs; Structure-Activity Relationship | 2001 |
In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
Topics: Amyloid Precursor Protein Secretases; Antineoplastic Agents; Apoptosis; Benzamides; Benzodiazepinones; Carbamates; Cell Cycle; Cell Division; Cell Line, Tumor; Daunorubicin; Dexamethasone; Dipeptides; DNA, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Humans; Imatinib Mesylate; In Vitro Techniques; Leukemia-Lymphoma, Adult T-Cell; Mutation; Neoplasm Proteins; Oncogene Proteins, Fusion; Piperazines; Pyrimidines; Receptor, Notch1; Sequence Analysis, DNA; Vincristine | 2008 |